+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

High-Grade Glioma - Pipeline Review, H2 2019 - Product Thumbnail Image

High-Grade Glioma - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 568 Pages
  • Global
From
From
From
From
From
Brain Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Brain Cancer Treatment Drugs Markets in China

  • Report
  • September 2023
  • 234 Pages
  • China
From
Zortress - API Insight, 2022 - Product Thumbnail Image

Zortress - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zortress- Drug Insight, 2019 - Product Thumbnail Image

Zortress- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more